212. Shots Across the Bow: Debates in Vaccinology
Saturday, October 7, 2017: 8:30 AM-10:00 AM
Room: 06DE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss the complexities of the use of pneumococcal vacicnes in adults
  • list the benefits and risks of using rotavirus vaccine in an inpatient setting in a very immune naive population
  • discuss the future of the use of LAIV in the United States

Target Audience: Academicians, Clinicians, Epidemiologists, Healthcare workers, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Pharmacists, Public health practitioners, Vaccinologists

Tracks: Pediatric ID, Adult ID

Moderators:  H. Keipp Talbot, MD, MPH, Vanderbilt University Medical Center and Andrew Pavia, MD, FIDSA, FSHEA, FPIDS, University of Utah School of Medicine

8:30 AM
Should the Conjugate Pneumococcal Vaccines Be Used in Adults
Cynthia Whitney, MD, MPH, FIDSA

Ron Dagan, MD, FIDSA

9:00 AM
Rotavirus Vaccine Should Be Used in the NICU
Andi L. Shane, MD, MPH, MSc, FIDSA, FPIDS

Evan J. Anderson, MD

9:30 AM
LAIV Should Be Reintroduced Into the US Vaccination Program
Mark Loeb, MD, MSc

Emily T. Martin, MPH, PhD

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-304-L01-P


H. K. Talbot, Sanofi Pasteur: Research Contractor , Research support
Gilead: Research Contractor , Research support
MedImmune: Research Contractor , Research support
Sequirus: Scientific Advisor , Consulting fee
VaxInnate: Scientific Advisor , Consulting fee

A. Pavia, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.